Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Insmed Incorporated

Latest From Insmed Incorporated

Insmed Planning 2025 Launch For Brensocatib In Bronchiectasis

The drug maker anticipates a smooth regulatory path and has already begun to rapidly expand its sales force across most of the US.

Clinical Trials Business Strategies

EHA Preview: ASCO Overlap Gives Smaller Companies Chance To Shine

Cargo Therapeutics has got an early boost from its abstract to be presented the European meeting, while Shattuck has suffered on safety doubts for its CD47 inhibitor.

Clinical Trials Commercial

With A Transformational Year Underway, Insmed Ramps Up

With a reliable source of revenue in Arikayce and two key pulmonary late-stage trials reading out, Insmed aims to keep its commercial momentum going.

Clinical Trials Commercial

AN2 Looks To Shift Gears On Phase III Epetraborole Trial On Potentially Lackluster Results

The company said it was pausing enrollment in the Phase III segment of its Phase II/III trial because of efficacy in MAC lung disease.

Infectious Diseases Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
      • Site Specific
  • Biotechnology
    • Large Molecule
    • Liposomes
  • Other Names / Subsidiaries
    • Insmed, Inc.
    • Transave Inc.